• Explore /
  • Poster
  • / Phase 1B study of avelumab and whole brain radiotherapy (WBRT) in patients with leptomeningeal disease (LMD) from epithelial carcinomas: Final results and molecular analyses with single cell RNA sequencing.

Phase 1B study of avelumab and whole brain radiotherapy (WBRT) in patients with leptomeningeal disease (LMD) from epithelial carcinomas: Final results and molecular analyses with single cell RNA sequencing.

Abstract Poster

Authors

Yolanda Pina

Yolanda Pina

Moffitt Cancer Center, Tampa, FL

Yolanda Pina , Ann Chen , John Arrington , Robert J Macaulay , Nam D. Tran , James K Liu , Sepideh Mokhtari , Jiannong Li , Vincent Law , Solmaz Sahebjam , Kamran A. Ahmed , Ben C. Creelan , Jhanelle Elaine Gray , Brittany Evernden , Nikhil I. Khushalani , Inna Smalley , Michael A. Vogelbaum , Michael Yu , Keiran Smalley , Peter A. J. Forsyth

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Immunotherapy

Track

Developmental Therapeutics—Immunotherapy

Sub Track

PD1/PD-L1 Inhibitor Combinations

Clinical Trial Registration Number

NCT03719768

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 2598)

DOI

10.1200/JCO.2023.41.16_suppl.2598

Abstract #

2598

Poster Bd #

440

Abstract Disclosures

Similar Posters

First Author: Scott N. Gettinger

First Author: Renata Ferrarotto

First Author: John M. Varlotto

First Author: Naixin Ding